NCT05217771

Effect Of High Tone Power Therapy On Selected Symptoms In Post Covid Syndrome

October 6 University·ClinicalTrials.gov·otherActive, not recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Rehabilitation
Drug/Device/Intervention
High tone power therapy group
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
October 6 University
Location
Cairo, Egypt
Timeline & enrollment
Phase
N/A
Start date
Nov 10, 2021
End date
Nov 20, 2022
Enrollment
56 participants
Primary outcome

Six-Minute Walk Test,Chalder Fatigue Scale: score can range from 0 to 33, with a higher score indicating greater fatigue.

Summary

The Coronavirus Disease 2019 (COVID-19) is a highly transmittable and pathogenic viral
 infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2), which
 emerged in Wuhan, China in December 2019 and its spread around the world has been rapid
 (Rathi et al., 2021; Vakili et al., 2021). COVID-19 impacts on economy, society, education ,
 neurological, psychiatric and psychosocial impairments , increasing the burden of disease and
 disability throughout the world have been studied by several authors (Phillips et al., 2020;
 Pragholapati, 2020).
 
 COVID-19 may lead to greater risks of long-term scarring, permanently lower economic
 activity, a significant increase in the prevalence of chronic illness, social distancing,
 isolation, changes in teaching and learning strategies to decrease of number of days of
 education, the number of social contacts each day is limited (Minister & Majesty, 2020;
 Almomani et al., 2021) .

ICD-10 classifications
Care involving use of rehabilitation proceduresDrug rehabilitationCare involving use of other rehabilitation proceduresCare involving use of rehabilitation procedure, unspecifiedPersonal history of rehabilitation measures
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05217771
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05217771 through Pure Global AI's free database. This phase not specified trial is sponsored by October 6 University and is currently Active, not recruiting. The study focuses on Rehabilitation. Target enrollment is 56 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.